Publications by authors named "Mei Ching Liu"

Claim this Profile
T
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, Tadeusz Pienkowski, Young-Hyuck Im, Mei-Ching Liu

Mol Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial.
Tamas Hickish, Ajay Mehta, Mei-Ching Liu, Chiun-Sheng Huang, Rajendra Singh Arora

Breast Cancer Res Treat· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study.
Chiun-Sheng Huang, Youngsen Yang, Ava Kwong, Shin-Cheh Chen, Ling-Ming Tseng, Mei-Ching Liu

Breast Cancer Res Treat· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Debu Tripathy, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Mei-Ching Liu

Lancet Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
Hong-Hwa Chen, Jen-Kou Lin, Joe-Bin Chen, Chieh-Han Chuang, Mei-Ching Liu

Asia Pac J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer.
Giampaolo Bianchini, Astrid Kiermaier, Giulia Valeria Bianchi, Young-Hyuck Im, Tadeusz Pienkowski, Mei-Ching Liu

Breast Cancer Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Luca Gianni, Tadeusz Pienkowski, Young-Hyuck Im, Ling-Ming Tseng, Mei-Ching Liu

Lancet Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
Yu-Yi Huang, Pei-Ing Lee, Mei-Ching Liu, Chien-Chih Chen, Kuo-Cheng Huang

Clin Nucl Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.
Heather-Jane Au, Wolfgang Eiermann, Nicholas J Robert, Tadeusz Pienkowski, John Crown, Mei-Ching Liu

Oncologist· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer.
Skye Hung-Chun Cheng, Stella Y Tsai, Ben-Long Yu, Cheng-Fang Horng, Chii-Ming Chen, Mei-Ching Liu

Int J Radiat Oncol Biol Phys· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Luca Gianni, Tadeusz Pienkowski, Young-Hyuck Im, Laslo Roman, Ling-Ming Tseng, Mei-Ching Liu

Lancet Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underperformance of gallium-67 scan is greater in relapse than in initial staging, compared with FDG PET.
Yu-Yi Huang, Dong-Ling You, Mei-Ching Liu, Tran-Der Tan, Pei-Ing Lee

Clin Nucl Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant trastuzumab in HER2-positive breast cancer.
Dennis Slamon, Wolfgang Eiermann, Nicholas Robert, Tadeusz Pienkowski, Miguel Martin, Mei-Ching Liu

N Engl J Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it appropriate to apply the enhanced recovery program to patients undergoing laparoscopic rectal surgery?
Chien-Chih Chen, I-Ping Huang, Mei-Ching Liu, James Jer-Min Jian, Skye Hon-Chun Cheng

Surg Endosc· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status.
Po Sheng Yang, Chi Ming Chen, Mei Ching Liu, Jer Min Jian, Cheng Fang Horng, Ming Jiung Liu

Int J Radiat Oncol Biol Phys· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.
Carlos H Barrios, Mei-Ching Liu, Soo Chin Lee, Laurence Vanlemmens, Jean-Marc Ferrero

Breast Cancer Res Treat· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to quality indicators and survival in patients with breast cancer.
Skye H Cheng, C Jason Wang, Jin-Long Lin, Cheng-Fang Horng, Mei-Chun Lu, Mei-Ching Liu

Med Care· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Li-Jen Kuo, Mei-Ching Liu, James Jer-Min Jian, Cheng-Fang Horng, Tsun-I Cheng

Ann Surg Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
Ming-Yuan Lee, Tran-Der Tan, An-Chen Feng, Mei-Ching Liu

Am J Hematol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients.
Li-Han Hsu, Thomas C Soong, An-Chen Feng, Mei-Ching Liu

J Thorac Oncol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological analysis of malignant lymphoma in Taiwan, defined according to the World Health Organization classification.
Ming-Yuan Lee, Tran-Der Tan, An-Chen Feng, Mei-Ching Liu

Haematologica· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global breast cancer burden: variations in epidemiology and survival.
Gabriel N Hortobagyi, Jaime de la Garza Salazar, Kathleen Pritchard, Dino Amadori, Renate Haidinger, Mei-Ching Liu

Clin Breast Cancer· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transanal local wide excision for rectal adenocarcinoma.
Chien-Chih Chen, Shuh-Yan Leu, Mei-Ching Liu, James Jer-Min Jian, Chii-Ming Chen

Hepatogastroenterology· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy.
Li-Jen Kuo, Ming-Chih Chern, Mei-Hua Tsou, Mei-Ching Liu, James Jer-Min Jian

Dis Colon Rectum· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients.
Jason Chia-Hsien Cheng, Mei-Ching Liu, Stella Y Tsai, Wei-Tse Fang, James Jer-Min Jian

Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis